查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1298887

特色仿制药市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球特种仿制药市场规模达到674亿美元。展望未来，IMARC集团预计，到2028年，市场规模将达到1254亿美元，在2023-2028年期间的增长率（CAGR）为10.8%。

特种仿制药是特种药物的仿制版本，一旦它们失去专利权。这些药物用于治疗慢性或复杂的健康状况，包括癌症、自身免疫性疾病、癫痫、艾滋病、肝炎、多发性硬化症、类风湿性关节炎等。与其品牌版本相比，特色仿制药具有成本效益，因为它们不需要昂贵的开发和营销成本。

与传统仿制药相比，特殊仿制药市场更加集中，参与者较少，因为它们的生产要求复杂，资本成本较高，而且由于患者人数较少，产量相对较低。这导致与品牌药相比，价格降低得更少，因此，与传统仿制药相比，利润率更高。特种仿制药需要特殊的处理、管理和监测，一般需要事先授权才能订购。目前，全球特种仿制药市场受到几个因素的推动，如人口老龄化加剧，一些品牌特种药的专利到期，各种威胁生命的疾病如癌症、多发性硬化症、艾滋病等的发病率增加，医疗机构的成本控制措施，新兴市场的增长等。

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：全球特殊非专利药市场：简介

第5章：为什么特色仿制药如此有利可图？

第六章：全球特色仿制药市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 按给药途径分類的市场
  • 按适应症分類的市场
  • 按销售渠道分類的市场
  • 按地区分類的市场
  • 市场预测
  • SWOT分析
    • 概况
    • 优势
    • 劣势
    • 机会
    • 威胁
  • 价值链分析
  • 波特斯五力分析
    • 概述
    • 买方讨价还价能力
    • 供应商的讨价还价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 关键的市场驱动因素和成功因素

第7章 ：按给药途径分類的市场

  • 注射剂
    • 市场趋势
    • 市场预测
  • 口服
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第8章：按适应症分類的市场

  • 肿瘤学
    • 市场趋势
    • 市场预测
  • 自身免疫性疾病
    • 市场趋势
    • 市场预测
  • 传染性疾病
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按分销渠道分類的市场

  • 零售药店
    • 市场趋势
    • 市场预测
  • 专业药店
    • 市场趋势
    • 市场预测
  • 医院药房
    • 市场趋势
    • 市场预测

第十章：按地区分類的市场

  • 北美洲
    • 市场概况
    • 市场表现
    • 按国家分類的市场
      • 美国

10.1.3.1.1 市场趋势

10.1.3.1.2 市场预测

      • 加拿大

10.1.3.2.1 市场趋势

10.1.3.2.2 市场预测

    • 市场预测

10.2 欧洲

    • 市场概况
    • 市场表现
    • 按国家分類的市场
      • 意大利

10.2.3.1.1 市场趋势

10.2.3.1.2 市场预测

      • 德国

10.2.3.2.1 市场趋势

10.2.3.2.2 市场预测

      • 法国

10.2.3.3.1 市场趋势

10.2.3.3.2 市场预测

      • 英国

10.2.3.4.1 市场趋势

10.2.3.4.2 市场预测

      • 西班牙

10.2.3.5.1 市场趋势

10.2.3.5.2 市场预测

    • 市场预测
  • 亚太地区
    • 市场概况
    • 市场表现
    • 按国家分類的市场
      • 日本

10.3.3.1.1 市场趋势

10.3.3.1.2 市场预测

      • 中国

10.3.3.2.1 市场趋势

10.3.3.2.2 市场预测

      • 印度

10.3.3.3.1 市场趋势

10.3.3.3.2 市场预测

      • 韩国

10.3.3.4.1 市场趋势

10.3.3.4.2 市场预测

    • 市场预测
  • 拉美地区
    • 市场概况
    • 市场表现
    • 按国家分類的市场
      • 巴西

10.4.3.1.1 市场趋势

10.4.3.1.2 市场预测

      • 墨西哥

10.4.3.2.1 市场趋势

10.4.3.2.2 市场预测

    • 市场预测
  • 中东和非洲
    • 市场概况
    • 市场表现
    • 市场预测

第十一章 ：竞争格局

  • 市场结构
  • 主要竞争者
  • 主要竞争者简介
    • Teva Pharmaceuticals Industries
    • Akorn, Inc.
    • Mylan N.V.
    • Mallinckrodt
    • Sandoz International GmbH
    • Pfizer, Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals
    • Apotex Corp.
    • Endo International plc.
Product Code: SR112023A1219

The global specialty generics market size reached US$ 67.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 125.4 Billion by 2028, exhibiting a growth rate (CAGR) of 10.8% during 2023-2028.

Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global specialty generics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:

North America

United States

Canada

Europe

Italy

Germany

Spain

United Kingdom

France

Asia-Pacific

China

India

Japan

South Korea

Latin America

Brazil

Mexico

Middle East and Africa

Breakup by Route of Administration:

Injectables

Oral

Others

Breakup by Indication:

Oncology

Autoimmune Diseases

Infectious Diseases

Others

Breakup by Distribution channel:

Retail Pharmacies

Specialty Pharmacies

Hospital Pharmacies

Competitive Landscape:

The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

IMARC Group's latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Key Questions Answered in This Report

1. What is the size of the global specialty generics market?

2. What are the key factors driving the global specialty generics market?

3. What has been the impact of COVID-19 on the global specialty generics market?

4. What is the breakup of the global specialty generics market based on the route of administration?

5. What is the breakup of the global specialty generics market based on the indication?

6. What is the breakup of the global specialty generics market based on the distribution channel?

7. What are the key regions in the global specialty generics market?

8. Who are the key players/companies in the global specialty generics market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3   Executive Summary

4   Global Specialty Generics Market: Introduction

5   Why are Specialty Generics So Lucrative?

6   Global Specialty Generics Market

  • 6.1 Market Overview
  • 6.2 Market Performance
  • 6.3 Impact of COVID-19
  • 6.4 Market Breakup by Route of Administration
  • 6.5 Market Breakup by Indication
  • 6.6 Market Breakup by Distribution Channel
  • 6.7 Market Breakup by Region
  • 6.8 Market Forecast
  • 6.9 SWOT Analysis
    • 6.9.1 Overview
    • 6.9.2 Strengths
    • 6.9.3 Weaknesses
    • 6.9.4 Opportunities
    • 6.9.5 Threats
  • 6.10 Value Chain Analysis
  • 6.11 Porters Five Forces Analysis
    • 6.11.1 Overview
    • 6.11.2 Bargaining Power of Buyers
    • 6.11.3 Bargaining Power of Suppliers
    • 6.11.4 Degree of Competition
    • 6.11.5 Threat of New Entrants
    • 6.11.6 Threat of Substitutes
  • 6.12 Key Market Drivers and Success Factors

7   Market Breakup by Route of Administration

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Indication

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Autoimmune Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Infectious Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9   Market Breakup by Distribution Channel

  • 9.1 Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Specialty Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Hospital Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10  Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Overview
    • 10.1.2 Market Performance
    • 10.1.3 Market Breakup by Country
      • 10.1.3.1 United States
        • 10.1.3.1.1 Market Trends
        • 10.1.3.1.2 Market Forecast
      • 10.1.3.2 Canada
        • 10.1.3.2.1 Market Trends
        • 10.1.3.2.2 Market Forecast
    • 10.1.4 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Overview
    • 10.2.2 Market Performance
    • 10.2.3 Market Breakup by Country
      • 10.2.3.1 Italy
        • 10.2.3.1.1 Market Trends
        • 10.2.3.1.2 Market Forecast
      • 10.2.3.2 Germany
        • 10.2.3.2.1 Market Trends
        • 10.2.3.2.2 Market Forecast
      • 10.2.3.3 France
        • 10.2.3.3.1 Market Trends
        • 10.2.3.3.2 Market Forecast
      • 10.2.3.4 United Kingdom
        • 10.2.3.4.1 Market Trends
        • 10.2.3.4.2 Market Forecast
      • 10.2.3.5 Spain
        • 10.2.3.5.1 Market Trends
        • 10.2.3.5.2 Market Forecast
    • 10.2.4 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Overview
    • 10.3.2 Market Performance
    • 10.3.3 Market Breakup by Country
      • 10.3.3.1 Japan
        • 10.3.3.1.1 Market Trends
        • 10.3.3.1.2 Market Forecast
      • 10.3.3.2 China
        • 10.3.3.2.1 Market Trends
        • 10.3.3.2.2 Market Forecast
      • 10.3.3.3 India
        • 10.3.3.3.1 Market Trends
        • 10.3.3.3.2 Market Forecast
      • 10.3.3.4 South Korea
        • 10.3.3.4.1 Market Trends
        • 10.3.3.4.2 Market Forecast
    • 10.3.4 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Market Overview
    • 10.4.2 Market Performance
    • 10.4.3 Market Breakup by Country
      • 10.4.3.1 Brazil
        • 10.4.3.1.1 Market Trends
        • 10.4.3.1.2 Market Forecast
      • 10.4.3.2 Mexico
        • 10.4.3.2.1 Market Trends
        • 10.4.3.2.2 Market Forecast
    • 10.4.4 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Overview
    • 10.5.2 Market Performance
    • 10.5.3 Market Forecast

11  Competitive Landscape

  • 11.1 Market Structure
  • 11.2 Key Players
  • 11.3 Profiles of Key Players
    • 11.3.1 Teva Pharmaceuticals Industries
    • 11.3.2 Akorn, Inc.
    • 11.3.3 Mylan N.V.
    • 11.3.4 Mallinckrodt
    • 11.3.5 Sandoz International GmbH
    • 11.3.6 Pfizer, Inc.
    • 11.3.7 Sun Pharmaceutical Industries Ltd.
    • 11.3.8 Valeant Pharmaceuticals
    • 11.3.9 Apotex Corp.
    • 11.3.10 Endo International plc. 

 

List of Figures

  • Figure 1: Global: Specialty Generics Market: Major Drivers and Challenges
  • Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2022
  • Figure 4: Global: Specialty Generics Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2022
  • Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Specialty Generics Industry: SWOT Analysis
  • Figure 9: Global: Specialty Generics Industry: Value Chain Analysis
  • Figure 10: Global: Specialty Generics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2017 & 2022
  • Figure 12: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 13: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2017 & 2022
  • Figure 14: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 15: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2017 & 2022
  • Figure 16: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 17: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2017 & 2022
  • Figure 18: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 19: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2017 & 2022
  • Figure 20: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 21: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2017 & 2022
  • Figure 22: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 23: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2017 & 2022
  • Figure 24: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 25: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2017 & 2022
  • Figure 26: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2023-2028
  • Figure 27: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2017 & 2022
  • Figure 28: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2023-2028
  • Figure 29: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2017 & 2022
  • Figure 30: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2023-2028
  • Figure 31: North America: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Italy: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Germany: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: France: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Spain: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: China: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: India: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Middle East and Africa: Specialty Generics Market: Breakup by Country (in %), 2022
  • Figure 67: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2023-2028

List of Tables

  • Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2023-2028
  • Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2023-2028
  • Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2023-2028
  • Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2023-2028
  • Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2022 and 2028
  • Table 11: Global: Specialty Generics Market Structure
  • Table 12: Global: Specialty Generics Market: Key Players